Neuphoria Therapeutics Inc (NEUP) — Strategic Asset Allocation Index
Neuphoria Therapeutics Inc (NEUP) has a Strategic Asset Allocation Index of 0.3% as of December 2023. Strategic assets (PP&E of $- plus long-term investments of $81.07K) total $81.07K, measured against net assets of $29.04 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Neuphoria Therapeutics Inc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Neuphoria Therapeutics Inc Strategic Asset Allocation Index (2021–2021)
This chart shows how Neuphoria Therapeutics Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of December 2023, the index stands at 0.3%, representing strategic assets of $81.07K against net assets of $29.04 Million USD. For live market cap and overall valuation, see Neuphoria Therapeutics Inc (NEUP) market capitalisation.
Annual Strategic Asset Allocation Index for Neuphoria Therapeutics Inc (2021–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Neuphoria Therapeutics Inc from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Neuphoria Therapeutics Inc for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.3% | $119.00K | $- | $119.00K | $35.76 Million | — |